SEC Form 4 · accession 0001055726-15-000012
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Niranjan Sardesai
Officer — Chief Operating Officer
Period of report
Sep 30, 2015
Accepted (ET)
Sep 30, 2015 · 2:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 30, 2015 | P | 4,000 | $5.50 | A | 32,000 | D |
Table II — derivative securities
No Table II lines on this filing.